Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

End-of-Life Care and Survival without Major Brain Damage in Newborns at the Limit of Viability

García-Muñoz Rodrigo F.a · Urquía Martí L.a · García Hernández J.Á.b · Figueras Aloy J.c · García-Alix Pérez A.d · the SEN1500 Network of the Spanish Neonatal Society

Author affiliations

Divisions of aNeonatology and bObstetrics and Gynecology, Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, cDivision of Neonatology, Hopital Clinic, and dDivision of Neonatology, Hospital Sant Joan de Deu, Barcelona, Spain

Related Articles for ""

Neonatology 2017;111:234-239

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: April 05, 2016
Accepted: October 03, 2016
Published online: November 29, 2016
Issue release date: March 2017

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 3

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: https://www.karger.com/NEO

Abstract

Background: The probabilities of survival and survival without major brain damage (MBD) are low in newborns at the limit of viability. Survival without MBD constitutes a major concern for parents and professionals. Objectives: To know the probabilities of survival without MBD in newborns ≤26 weeks' gestational age (GA) relative to the total number of survivors, whether these probabilities vary with GA, and how end-of-life (EoL) decisions influence these results. Methods: We included all live-inborn patients of 22-26 weeks' GA, without major congenital anomalies, born in collaborating centers of the Spanish SEN1500 Network (2004-2010). MBD was defined as the presence of severe intraventricular hemorrhage and/or periventricular leukomalacia. Results: A total of 3,371 patients were born alive, 3,236 of whom were admitted to the neonatal intensive care unit (NICU). Survival without MBD was 44.4% among patients admitted to the NICU, increasing from 12.5% at 22 weeks to 57.9% at 26 weeks' GA. The proportion of survivors without MBD relative to the total number of survivors was 81.1%, and it was independent of GA. EoL decisions preceded one-third of all deaths and were more frequent among the most immature patients. Conclusions: The proportion of survivors without MBD, when referred to the total number of survivors, is relatively high and is independent of GA. EoL decisions after the occurrence of MBD seem to play an important role in this respect. These results support the attitude of “giving an opportunity” even to the most immature patients, if this is in accordance with the parents' wishes.

© 2016 S. Karger AG, Basel


References

  1. Costeloe K, Hennessy E, Gibson AT, Marlow N, Wilkinson AR; EPICure Study: Outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000;106:659-671.
  2. El-Metwally D, Vohr B, Tucker R: Survival and neonatal morbidity at the limits of viability in the mid 1990s: 22 to 25 weeks. J Pediatr 2000;137:616-622.
  3. Chan K, Ohlsson A, Synnes A, Lee DSC, Chien LY, Lee SK: The Canadian Neonatal Network: survival, morbidity, and resource use of infants of 25 weeks' gestational age or less. Am J Obstet Gynecol 2001;185:220-226.
  4. Larroque B, Bréart G, Kaminski M, Dehan M, André M, Burguet A, Grandjean H, Ledésert B, Lévêque C, Maillard F, Matis J, Rozé JC, Truffert P; Epipage Study Group: Survival of very preterm infants: Epipage, a population based cohort study. Arch Dis Child Fetal Neonatal Ed 2004;89:F139-F144.
  5. Vanhaesebrouck P, Allegaert K, Bottu J, Debauche C, Devlieger H, Docx M, François A, Haumont D, Lombet J, Rigo J, Smets K, Vanherreweghe I, Van Overmeire B, Van Reempts P; Extremely Preterm Infants in Belgium Study Group: The EPIBEL study: outcomes to discharge from hospital for extremely preterm infants in Belgium. Pediatrics 2004;114:663-675.
  6. Markestad T, Kaarensen PI, Ronnestad A, Reigstad H, Lossius K, Medbø S, Zanussi G, Engelund IE, Skjaerven R, Irgens LM; Norwegian Extreme Prematurity Study Group: Early, morbidity, and need of treatment among extremely premature infants. Pediatrics 2005;115:1289-1298.
  7. Itabashi K, Horiuchi T, Kusuda S, Kabe K, Itani Y, Nakamura T, Fujimura M, Matsuo M: Mortality rates for extremely low birth weight infants born in Japan in 2005. Pediatrics 2009;123:445-450.
  8. Costeloe KL, Hennesy EM, Haider S, Stacey F, Marlow N, Draper ES: Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPIcure studies). BMJ 2012;345:e7976.
  9. García-Muñoz Rodrigo F, Díez Recino AL, García-Alix Pérez A, Figueras Aloy J, Vento Torres M; SEN1500 Network: Changes in perinatal care and outcomes in newborns at the limit of viability in Spain: the EPI-SEN study. Neonatology 2015;107:120-129.
  10. Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, Laptook AR, Sánchez PJ, Van Meurs KP, Wyckoff M, Das A, Hale EC, Ball MB, Newman NS, Schibler K, Poindexter BB, Kennedy KA, Cotten CM, Watterberg KL, D'Angio CT, DeMauro SB, Truog WE, Devaskar U, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network: Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 2015;314:1039-1051.
  11. Shinwell ES: Ethics of birth at the limits of viability: the risky business of prediction. Neonatology 2015;107:317-320.
  12. Meadow W, Lagatta J, Andrews B, Lantos J: The mathematics of morality for neonatal resuscitation. Clin Perinatol 2012;39:941-956.
  13. García-Muñoz Rodrigo F, García-Alix Pérez A, García Hernández JA, Figueras Aloy J; SEN1500 Network: Morbidity and mortality in newborns at the limit of viability in Spain: a population-based study. An Pediatr (Barc) 2014;80:348-856.
  14. Moro Serrano M, Fernández Pérez C, Figueras Alloy J, Pérez Rodríguez J, Coll E, Doménech Martínez E, Jiménez R, Pérez Sheriff V, Quero Jiménez J, Roques Serradilla V; Grupo SEN1500: SEN1500: design and implementation of a registry of infants weighing less than 1,500 g at birth in Spain. An Pediatr (Barc) 2008;68:181-188.
  15. Papile LA, Burstein J, Burstein R, Koffler H: Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 g. J Pediatr 1978;92:529-534.
  16. Luu TM, Ment LR, Schneider KC, Katz KH, Allan WC, Vohr BR: Lasting effects of preterm birth and neonatal brain hemorrhage at 12 years of age. Pediatrics 2009;123:1037-1044.
  17. Farooqi A, Hägglöf B, Sedin G, Serenius F: Impact at age 11 years of major neonatal morbidities in children born extremely preterm. Pediatrics 2011;127:e1247-e1257.
  18. Bodeau-Livinec F, Marlow N, Ancel P-Y, Kurinczuk JJ, Costeloe K, Kaminski M: Impact of intensive care practices on short-term and long-term outcomes for extremely preterm infants: comparison between the British Isles and France. Pediatrics 2008;122:e1014-e1021.
  19. Rysavy MA, Tyson JE: The problem and promise of prognosis research. JAMA Pediatr 2016;170:411-412.
  20. Seri I, Evans J: Limits of viability: definition of the gray zone. J Perinatol 2008;28(suppl 1):S4-S8.
  21. Mahgoub L, van Manen M, Byrne P, Tyebkhan JM: Policy change for infants born at the “cusp of viability”: a Canadian NICU experience. Pediatrics 2014;134:e1405-e1410.
  22. Rysavy MA, Li L, Bell EF, Das A, Hintz SR, Stoll BJ, Vohr BR, Carlo WA, Shankaran S, Walsh MC, Tyson JE, Cotten CM, Smith PB, Murray JC, Colaizy TT, Brumbaugh JE, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network: Between-hospital variation in treatment and outcomes in extremely preterm infants. N Engl J Med 2015;372:1801-1811.
  23. Benders MJ, Kersbergen KJ, de Vries LS: Neuroimaging of white matter injury, intraventricular and cerebellar hemorrhage. Clin Perinatol 2014;41:69-82.
  24. Plaisier A, Raets MM, Ecury-Goossen GM, Govaert P, Feijen-Roon M, Reiss IK, Smit LS, Lequin MH, Dudink J: Serial cranial ultrasonography or early MRI for detecting preterm brain injury? Arch Dis Child Fetal Neonatal Ed 2015;100:F293-F300.
  25. Ochiai M, Kinjo T, Takahata Y, Iwayama M, Abe T, Ihara K, Ohga S, Fukushima K, Kato K, Taguchi T, Hara T: Survival and neurodevelopmental outcome of preterm infants born at 22-24 weeks of gestational age. Neonatology 2014;105:79-84.
  26. Sugiura T, Kouwaki M, Togawa Y, Sugimoto M, Togawa T, Koyama N: Neurodevelopmental outcomes at 18 months' corrected age of infants born at 22 weeks of gestation. Neonatology 2011;100:228-232.
  27. Marlow N, Wolke D, Bracewell MA, Samara M; EPICure Study Group: Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 2005;352:9-19.
  28. Moore T, Hennessy EM, Myles J, Johnson SJ, Draper ES, Costeloe KL, Marlow N: Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ 2012;345:e7961.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: April 05, 2016
Accepted: October 03, 2016
Published online: November 29, 2016
Issue release date: March 2017

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 3

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: https://www.karger.com/NEO


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.